| For Practicing Oncologists |
  See all
 | Articles: Pharmacology/Therapy |
Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG)
Blood, 12/27/07
Interferon and low-dose methotrexate improve outcome in refractory mycosis fungoides/Sézary syndrome
Cancer Biotherapy & Radiopharmaceuticals, 12/27/07
NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma
Experimental Hematology, 12/27/07
 | | Sponsor |
Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells
Blood, 12/27/07
PKC mTOR pathway: a new target for rituximab therapy in follicular lymphoma
Blood, 12/27/07
Alemtuzumab-Induced Resolution of Refractory Cutaneous Chronic Graft-Versus-Host Disease
Biology of Blood and Marrow Transplantation, 12/27/07
L-arginine reduces cell proliferation and ornithine decarboxylase activity in patients with colorectal adenoma and adenocarcinoma
Clinical Cancer Research, 12/26/07
Histopathological response after preoperative radiochemotherapy in rectal carcinoma is associated with improved overall survival
Journal of Surgical Oncology, 12/26/07
Early or up-front radiotherapy improved survival of localized extranodal NK/T-cell lymphoma, nasal-type in the upper aerodigestive tract
International Journal of Radiation Oncology*Biology*Physics, 12/26/07
Outcome after pulmonary radiotherapy in Wilms' tumor patients with pulmonary metastases at diagnosis: A UK Children's Cancer Study Group, Wilms' Tumour Working Group Study
International Journal of Radiation Oncology*Biology*Physics, 12/26/07
|
|
Receive daily email updates on Pharmacology/Therapy
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
250 Available Pages
 |
 |
| Sponsor |
|
|
| Read a Different Specialty |
 |
|
|
|
|
| Profession Index |
|
|
|
|
|
|
 |
| Sponsor |
|
|
| Sponsor |
|
